You are here: Industry Insights > OCD

News List

Alembic Pharmaceuticals gets USFDA approval for Clomipramine Hydrochloride Capsules expresspharma
August 06, 2021
The capsules are indicated for the treatment of obsessions and compulsions in patients with Obsessive Compulsive Disorder (OCD).
Having OCD May Triple a Person's Odds for a Stroke drugs
May 31, 2021
Adults with obsessive-compulsive disorder, a common mental health condition known as OCD, may have more than triple the risk of having a stroke, according to a new report from Taiwan, Chinaese researchers.
Biohaven Begins Phase 3 Troriluzole Trial for Obsessive-Compulsive Disorder americanpharmaceuticalreview
January 11, 2021
Biohaven has commenced enrollment in a Phase 3 clinical trial assessing the efficacy and safety of troriluzole in patients with obsessive-compulsive disorder (OCD).
MagVenture Receives FDA Clearance for OCD Treatment americanpharmaceuticalreview
August 17, 2020
The U.S. Food and Drug Administration (FDA) has cleared MagVenture TMS Therapy® for adjunct treatment of Obsessive-Compulsive Disorder (OCD).
OCD to Examine Labs and Health Care transformation by data and digitization biospectrumasia
July 10, 2019
Ortho Clinical Diagnostics to Host Industry Conferences: 'Lab Leader Summit' and 'Healthcare Management in a Digital World'
FDA clears first magnetic, noninvasive device treatment for OCD fiercebiotech
August 21, 2018
The FDA granted de novo clearance to the first noninvasive device treatment for obsessive compulsive disorder, Brainsway’s transcranial magnetic stimulation system, adding a new therapy for adults alongside medication and psychotherapy.